Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001303446 | SCV001492693 | uncertain significance | not provided | 2020-09-12 | criteria provided, single submitter | clinical testing | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has been observed in individual(s) with clinical features of Alport syndrome (PMID: 22921432, 25183659, Invitae). This variant is also known as 4712+ 4709A>G and IVS48-345A>G. ClinVar contains an entry for this variant (Variation ID: 587122). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 22921432, 25183659). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change falls in intron 47 of the COL4A5 gene. It does not directly change the encoded amino acid sequence of the COL4A5 protein. |
Gene |
RCV001303446 | SCV002503913 | pathogenic | not provided | 2020-01-14 | criteria provided, single submitter | clinical testing | Non-canonical splice site variant demonstrated to result in loss-of-function (Nozu et al., 2014); No data available from control populations to assess the frequency of this variant; This variant is associated with the following publications: (PMID: 25183659, 22921432) |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000714336 | SCV000863808 | likely pathogenic | X-linked Alport syndrome | 2018-02-12 | no assertion criteria provided | clinical testing |